Delivery Order SPE2DB24D2106-SPE2DB25FAVXF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for BOTOX 200 Unit Vials with a ceiling value of $2,587.40. The delivery order carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 18, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, valued at $6,468.50 with completion targeted for September 9, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,569.85 on August 18, 2025, for the supply of Botox 100 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which is valued at $499,999,999 and remains...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,938.55 by the Defense Logistics Agency on August 19, 2025, for the supply of Botox 100 Unit Vials. The contract, which carries an ultimate completion date of September 10, 2025, was issued without set-aside designation. This delivery order represents one of many pharmaceutical supply contracts DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of BOTOX with a potential value of $5,537.76 and a completion date of February 29, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on July 22, 2025, for the supply of Botox 100 Unit Vials. The contract utilizes a firm fixed-price delivery model with an ultimate completion date of August 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVXFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare facilities. Performance will occur in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. This IDC framework enables the DLA to issue firm fixed-price orders for pharmaceutical products and medical supplies supporting military health facilities worldwide. The award of BOTOX vials for federal healthcare distribution aligns with the contractor's established portfolio of specialty pharmaceutical products, which includes oncology treatments, biologics, vaccines, and other prescription medications essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 8/4/25 |